Episode 208: Bad News, Good News
Osterholm Update
CIDRAP
4.8 • 3K Ratings
🗓️ 7 May 2026
⏱️ 63 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello and welcome to the Oström Update, a podcast about infectious diseases and public health, |
| 0:13.8 | featuring Dr. Michael Osterholm. |
| 0:17.0 | Dr. Ostrome is an internationally recognized medical detective and director of the Center for Infectious Disease Research and Policy, or Sidrap, at the University of Minnesota. |
| 0:26.7 | In this podcast, Dr. Ostrome draws an over 50 years of experience in infectious disease epidemiology to provide straight talk on the latest infectious disease outbreaks, |
| 0:40.6 | counter misinformation and disinformation about vaccines, |
| 0:46.0 | and distill the complex and ever-evolving public health threats facing our world. |
| 0:49.5 | I'm Chris Dahl, reporter for Sidrapp News, |
| 1:00.4 | and I'm your host for these conversations. Welcome back, everyone, to another episode of the Oström Update podcast. |
| 1:04.6 | From the moment it received emergency use authorization from the Food and Drug Administration, |
| 1:09.5 | Pax Lovit has been one of the primary |
| 1:11.3 | antiviral medications for adults with COVID-19 who are at risk for hospitalization or death. |
| 1:17.3 | Some of you might remember the if it's COVID Paxlovid tagline created by Drug Maker Pfizer |
| 1:22.8 | and its advertisements for the truck. But the results of two randomized clinical trials |
| 1:27.1 | published recently |
| 1:27.9 | in the New England Journal of Medicine found that Pax Lode failed to reduce hospitalizations |
| 1:32.5 | or deaths in adults with risk factors for severe COVID-19 outcomes. On its face, that seems like |
| 1:39.3 | bad news. But as emergency physician, researcher, and writer Dr. Jeremy Faust, noted recently in his |
| 1:45.0 | inside medicine substact column, it also contains some good news, because there were no deaths |
| 1:50.7 | from any cause in the study. And that tells us something about where we are with COVID. |
| 1:56.6 | Yes, the fact that two major studies conducted in 2022-2020 to 24 failed to show this benefit |
| 2:02.0 | for Paxlovod is caused for celebration, Faust wrote. |
| 2:05.9 | COVID-19 is no longer the massive mortality threat it once was. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from CIDRAP, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of CIDRAP and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

